ivermectin oral / Generic mfg. 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 


«12...910111213141516171819...129130»
  • ||||||||||  ivermectin oral / Generic mfg.
    Journal:  The political polarization of COVID-19 treatments among physicians and laypeople in the United States. (Pubmed Central) -  Feb 8, 2023   
    Using a set of embedded experiments, we demonstrate that partisans perceive scientific evidence differently when it pertains to a politicized treatment (ivermectin), relative to when the treatment is not identified. These results highlight the extent to which political ideology is increasingly relevant for understanding beliefs, even among expert decision makers such as physicians.
  • ||||||||||  ivermectin oral / Generic mfg.
    Journal, Adverse events:  Pharmacovigilance follow-up of patients in the context of the COVID-19 pandemic. (Pubmed Central) -  Feb 8, 2023   
    This signal has contributed to the evolution of the recommendations for these 2 drugs. The methodology of this survey has been taken over and is still going on for the pharmacovigilance monitoring of vaccines against COVID-19, for monoclonal antibodies used against COVID-19 and also for Paxlovid
  • ||||||||||  Veramyst (fluticasone furoate nasal spray) / GSK
    Trial completion date, Trial primary completion date:  ACTIV-6: COVID-19 Study of Repurposed Medications (clinicaltrials.gov) -  Feb 2, 2023   
    P3,  N=15000, Recruiting, 
    No abstract available Trial completion date: Mar 2023 --> Mar 2024 | Trial primary completion date: Mar 2023 --> Mar 2024